Destination XL Group Inc. (DXLG) is Trading Lower on Unusual Volume for January 27

Equities Staff  |

Destination XL Group Inc. (DXLG) experienced unusually high volume on Jan. 27, as the stock lost 2.71% to a closing price of $4.30. The stock saw 187,689 shares trade hands over the course of the day on 749 trades. Given that the stock’s average daily volume over the last month has been 112,601 shares a day, this represents a pretty substantial spike over the norm.

Destination XL Group Inc. has a P/B ratio of 2.47. The stock has traded between $6.70 and $4.10 over the last 52-weeks, its 50-day SMA is now $4.93, and its 200-day SMA $5.20.

Destination XL Group Inc along with its subsidiaries is engaged in specialty retail of big & tall men's apparel with retail and direct operations in the United States and London, England and direct operations in Canada.

Headquartered in Canton, MA, Destination XL Group Inc. has 2,435 employees and is currently under the leadership of CEO David A. Levin.

For a complete fundamental analysis analysis of Destination XL Group Inc., check out’s Stock Valuation Analysis report for DXLG. To see the latest independent stock recommendations from’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change










Q BioMed CEO provides a Corporate Update

Denis Corin, CEO of Q BioMed Inc. ”Q“, a biomedical acceleration and development company, focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides a corporate update.

Emerging Growth

Lexaria Bioscience Corp

Lexaria Bioscience Corp is a food sciences company. It has two distinct consumer product brands: ViPova and Lexaria Energy. It uses patent pending technology to infuse hemp oil ingredients within…